[Beta-blocker withdrawal syndrome].
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects*; D000787:Angina Pectoris / Q000139:chemically induced; D000818:Animals; D001145:Arrhythmias, Cardiac / Q000139:chemically induced; D002395:Catecholamines / Q000097:blood; D003327:Coronary Disease / Q000139:chemically induced; D004305:Dose-Response Relationship, Drug; D004361:Drug Tolerance; D006801:Humans; D006973:Hypertension / Q000139:chemically induced; D010974:Platelet Aggregation / Q000187:drug effects; D011433:Propranolol / Q000009:adverse effects; D051381:Rats; D011943:Receptors, Adrenergic, beta / Q000187:drug effects; D012189:Retrospective Studies; D013375:Substance Withdrawal Syndrome / Q000097:blood / Q000209:etiology*; D013963:Thyroid Hormones / Q000097:blood; D013997:Time Factors
D000319:Adrenergic beta-Antagonists; D002395:Catecholamines; D011943:Receptors, Adrenergic, beta; D013963:Thyroid Hormones; D011433:Propranolol
Sindrom otmeny beta-blokatorov.